Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Study Identifier
191622-057
CT.gov Identifier
NCT00076687
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Stroke
  • Movement Disorders - Other
    • Study Drug
  • botulinum toxin Type A
  • saline
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Abnormal pulmonary function test results; * focal, upper limb spasticity, upper motor neuron syndrome
    Exclusion Criteria:
    * Previous exposure to botulinum toxin of any serotype

    Protocol Summary

    The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity

    Study Locations

    Location
    Status
    Location
    Miami, Florida, United States
    Status
    Not applicable
    Location
    Prague, Czech Republic
    Status
    Not applicable
    Location
    Szeged, Hungary
    Status
    Not applicable
    Location
    Warsaw, Poland
    Status
    Not applicable